sponsored
PatientsVille.com Logo

PatientsVille

Magnevist Mobility Decreased Side Effects

Magnevist Mobility Decreased Side Effect Reports


The following Magnevist Mobility Decreased side effect reports were submitted by healthcare professionals and consumers.

This information will help you understand how side effects, such as Mobility Decreased, can occur, and what you can do about them.

A side effect could appear soon after you start Magnevist or it might take time to develop.



Nephrogenic Systemic Fibrosis, Arthralgia, Musculoskeletal Stiffness, Joint Contracture, Mobility Decreased, Gait Disturbance, Abasia, Skin Discolouration, Joint Stiffness

This Mobility Decreased side effect was reported by a health professional from US. A 43-year-old patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging abdominal,complications of transplanted kidney,abdominal pain,angiogram,intestinal ischaemia,nuclear magnetic resonance imaging brain,blood prolactin increased. The patient was prescribed Magnevist (dosage: 20 Ml, Once), which was started on Oct 05, 2005. Concurrently used drugs: NA. When starting to take Magnevist the consumer reported the following symptoms:
  • Nephrogenic Systemic Fibrosis
  • Arthralgia
  • Musculoskeletal Stiffness
  • Joint Contracture
  • Mobility Decreased
  • Gait Disturbance
  • Abasia
  • Skin Discolouration
  • Joint Stiffness
These side effects may potentially be related to Magnevist.
Pain, Musculoskeletal Pain, Myalgia, Mobility Decreased

This Mobility Decreased Magnevist side effect was reported by a consumer or non-health professional from US on Sep 15, 2012. A Female , 75 years of age, was diagnosed with and was treated with Magnevist. The patient presented the following health conditions:
  • Pain
  • Musculoskeletal Pain
  • Myalgia
  • Mobility Decreased
. Magnevist dosage: Unk. Additional drugs used at the same time: NA.
Nephrogenic Systemic Fibrosis, Deformity, Scar, Mobility Decreased, Skin Induration, Gait Disturbance, Oedema Peripheral, Movement Disorder

This is a Magnevist side effect report of a 28-year-old patient (weight:NA) from US, suffering from the following symptoms/conditions: imaging procedure,nuclear magnetic resonance imaging brain, who was treated with Magnevist (dosage:20 Ml, Once, start time: Mar 18, 2005), combined with: NA., and developed a serious reaction and a Mobility Decreased side effect. The patient presented with:
  • Nephrogenic Systemic Fibrosis
  • Deformity
  • Scar
  • Mobility Decreased
  • Skin Induration
  • Gait Disturbance
  • Oedema Peripheral
  • Movement Disorder
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Magnevist treatment in patients suffering from imaging procedure,nuclear magnetic resonance imaging brain, resulting in Mobility Decreased.

Nephrogenic Systemic Fibrosis, Post Thrombotic Syndrome, Skin Induration, Skin Hyperpigmentation, Rash, Ocular Icterus, Skin Discolouration, Skin Mass, Mobility Decreased

A 50-year-old female patient (weight: NA) from US with the following symptoms: renal scan,cardiac imaging procedure started Magnevist treatment (dosage: Unk) on Feb 03, 2004. Soon after starting Magnevist treatment, the consumer experienced several side effects, including:
  • Nephrogenic Systemic Fibrosis
  • Post Thrombotic Syndrome
  • Skin Induration
  • Skin Hyperpigmentation
  • Rash
  • Ocular Icterus
  • Skin Discolouration
  • Skin Mass
  • Mobility Decreased
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Magnevist side effects, such as Mobility Decreased.
Livedo Reticularis, Mobility Decreased, Skin Hypertrophy, Anhedonia, Skin Swelling, Joint Stiffness, Scar, Skin Fibrosis, Scab

A female patient from UNITED STATES was prescribed and started Magnevist on Jun 15, 2012. Patient felt the following Magnevist side effects: livedo reticularis, mobility decreased, skin hypertrophy, anhedonia, skin swelling, joint stiffness, scar, skin fibrosis, scab Additional patient health information: Female , 58 years of age, weighting 154.3 lb, The consumer reported the following symptoms: was diagnosed with and. Magnevist dosage: 20 Ml, Unk. Concurrently used drugs:
  • Klonopin (0.5 Mg, Hs)
  • Calcitriol (0.5 Mg, Bid)
  • Norvasc (5 Mg, Unk)
  • Zemplar (10 Mcg)
  • Epogen
  • Folbee (1 Tablet, Qd)
  • Immunosuppressive Agents (Unk)
  • Sensipar
Emotional Distress, Injury, Mobility Decreased, Musculoskeletal Stiffness, Abasia, Fibrosis, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Pain

This report suggests a potential Magnevist Mobility Decreased side effect(s) that can have serious consequences. A 54-year-old patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): NA and used Magnevist (dosage: NA) starting Dec 12, 2000. Soon after starting Magnevist the patient began experiencing various side effects, including:
  • Emotional Distress
  • Injury
  • Mobility Decreased
  • Musculoskeletal Stiffness
  • Abasia
  • Fibrosis
  • Nephrogenic Systemic Fibrosis
  • Skin Hypertrophy
  • Pain
Drugs used concurrently:NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Mobility Decreased, may still occur.
Skin Fibrosis, Mobility Decreased, Fatigue, Erythema, Pain, Scar, Nephrogenic Systemic Fibrosis, Skin Exfoliation

An adverse event was reported by a health professional on Jun 01, 2012 by a Female taking Magnevist (dosage: 20 Ml, Unk) was diagnosed with and. Location: UNITED STATES , 58 years of age, weighting 171.0 lb, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Magnevist side effects: skin fibrosis, mobility decreased, fatigue, erythema, pain, scar, nephrogenic systemic fibrosis, skin exfoliation. Additional medications/treatments:
Muscular Weakness, Joint Range Of Motion Decreased, Oedema Peripheral, Skin Hyperpigmentation, Pain, Skin Hypertrophy, Joint Stiffness, Mobility Decreased, Musculoskeletal Stiffness

This Mobility Decreased problem was reported by a health professional from UNITED STATES. A 50-year-old patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Aug 09, 2006 a consumer started treatment with Magnevist (dosage: 30 Ml, Once). The following drugs/medications were being taken at the same time: NA. When commencing Magnevist, the patient experienced the following unwanted symptoms /side effects:
  • Muscular Weakness
  • Joint Range Of Motion Decreased
  • Oedema Peripheral
  • Skin Hyperpigmentation
  • Pain
  • Skin Hypertrophy
  • Joint Stiffness
  • Mobility Decreased
  • Musculoskeletal Stiffness
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Mobility Decreased, may become evident only after a product is in use by the general population.
Joint Range Of Motion Decreased, Skin Hyperpigmentation, Anhedonia, Pain, Nephrogenic Systemic Fibrosis, Mobility Decreased, Muscular Weakness, Ephelides, Anxiety

This is a Magnevist side effect report of a 56-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: renal mass,dialysis and was treated with Magnevist (dosage: NA) starting Apr 01, 2005. Concurrently used drugs:
  • Sensipar (90 Mg, Qd)
  • Atenolol
  • Optimark
  • Prednisone Tab
  • Optimark
  • Optimark
  • Prograf
  • Optimark (15 Ml, Once)
Soon after that, the consumer experienced the following of symptoms:
  • Joint Range Of Motion Decreased
  • Skin Hyperpigmentation
  • Anhedonia
  • Pain
  • Nephrogenic Systemic Fibrosis
  • Mobility Decreased
  • Muscular Weakness
  • Ephelides
  • Anxiety
This opens a possibility that Magnevist could cause Mobility Decreased and that some female patients may be more susceptible.
Erythema, Skin Mass, Gait Disturbance, Rash Pruritic, Musculoskeletal Stiffness, Pain, Asthenia, Mobility Decreased, Arthralgia

This Mobility Decreased side effect was reported by a consumer or non-health professional from UNITED STATES on Mar 30, 2011. A female patient from UNITED STATES , 45 years of age, weighting 361.6 lb, was diagnosed with and was treated with Magnevist. Directly after treatment started, patient experienced the unwanted or unexpected Magnevist side effects: erythema, skin mass, gait disturbance, rash pruritic, musculoskeletal stiffness, pain, asthenia, mobility decreased, arthralgia. Magnevist dosage: NA.
Associated medications used:
  • Gabapentin
  • Losartan Potassium
  • Ibuprofen
  • Zithromax
These side effects may potentially be related to Magnevist.
Myalgia, Dyspnoea, Mobility Decreased, Muscle Tightness, Deformity, Skin Hyperpigmentation, Pain, Hypoaesthesia

This Mobility Decreased side effect was reported by a physician from UNITED STATES. A 49-year-old patient (weight:NA) experienced the following symptoms/conditions: nuclear magnetic resonance imaging. The patient was prescribed Magnevist (dosage: NA), which was started on Sep 27, 2002. Concurrently used drugs: NA. When starting to take Magnevist the consumer reported the following symptoms:
  • Myalgia
  • Dyspnoea
  • Mobility Decreased
  • Muscle Tightness
  • Deformity
  • Skin Hyperpigmentation
  • Pain
  • Hypoaesthesia
These side effects may potentially be related to Magnevist.
Scar, Movement Disorder, Pain, Fibrosis, Emotional Distress, Anxiety, Mobility Decreased, Skin Tightness

This Mobility Decreased Magnevist side effect was reported by a consumer or non-health professional from UNITED STATES on Aug 11, 2008. A male , weighting 295.0 lb, was treated with Magnevist. The patient presented the following health conditions:
  • Scar
  • Movement Disorder
  • Pain
  • Fibrosis
  • Emotional Distress
  • Anxiety
  • Mobility Decreased
  • Skin Tightness
. Magnevist dosage: NA. Additional drugs used at the same time: NA.
Nephrogenic Systemic Fibrosis, Scar, Skin Fibrosis, Mobility Decreased, Abasia, Oedema Peripheral, Arthralgia, Muscular Weakness, Musculoskeletal Stiffness

This is a Magnevist side effect report of a 56-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: nuclear magnetic resonance imaging abdominal,renal mass,nuclear magnetic resonance imaging brain,muscular weakness,disorientation,headache, who was treated with Magnevist (dosage:Unk, start time: 200504), combined with: NA., and developed a serious reaction and a Mobility Decreased side effect. The patient presented with:
  • Nephrogenic Systemic Fibrosis
  • Scar
  • Skin Fibrosis
  • Mobility Decreased
  • Abasia
  • Oedema Peripheral
  • Arthralgia
  • Muscular Weakness
  • Musculoskeletal Stiffness
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Magnevist treatment in female patients suffering from nuclear magnetic resonance imaging abdominal,renal mass,nuclear magnetic resonance imaging brain,muscular weakness,disorientation,headache, resulting in Mobility Decreased.
Renal Disorder, Immobile, Skin Disorder, Anxiety, Mobility Decreased, Major Depression, Rash, Nephrogenic Systemic Fibrosis

A patient (weight: NA) from UNITED STATES with the following symptoms: nuclear magnetic resonance imaging started Magnevist treatment (dosage: 19 Ml, Once) on Jan 01, 1998. Soon after starting Magnevist treatment, the consumer experienced several side effects, including:
  • Renal Disorder
  • Immobile
  • Skin Disorder
  • Anxiety
  • Mobility Decreased
  • Major Depression
  • Rash
  • Nephrogenic Systemic Fibrosis
. Concurrently used drugs:
  • Lyrica (Unk)
  • Tamsulosin Hcl
This finding indicates that some patients can be more vulnerable to developing Magnevist side effects, such as Mobility Decreased.
Nephrogenic Systemic Fibrosis, Joint Range Of Motion Decreased, Activities Of Daily Living Impaired, Muscular Weakness, Hypoaesthesia, Pain, Pallor, Dry Skin, Mobility Decreased

A patient from UNITED STATES was prescribed and started Magnevist on Feb 27, 2012. After Magnevist was administered, patient encountered several Magnevist side effects: nephrogenic systemic fibrosis, joint range of motion decreased, activities of daily living impaired, muscular weakness, hypoaesthesia, pain, pallor, dry skin, mobility decreased Additional patient health information: male , 63 years of age, weighting 134.5 lb, The consumer reported the following symptoms: . Magnevist dosage: NA. Concurrently used drugs:
  • Sensipar
  • Norvasc (2.5 Mg, Bid)
Mobility Decreased, Skin Disorder, Renal Disorder, Major Depression, Immobile, Injury, Emotional Distress, Nephrogenic Systemic Fibrosis

This report suggests a potential Magnevist Mobility Decreased side effect(s) that can have serious consequences. A patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): nuclear magnetic resonance imaging abdominal,dizziness,angiogram and used Magnevist (dosage: NA) starting Jan 01, 1998. Soon after starting Magnevist the patient began experiencing various side effects, including:
  • Mobility Decreased
  • Skin Disorder
  • Renal Disorder
  • Major Depression
  • Immobile
  • Injury
  • Emotional Distress
  • Nephrogenic Systemic Fibrosis
Drugs used concurrently:NA. Although Magnevist demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Mobility Decreased, may still occur.
Muscular Weakness, Mobility Decreased, Depression, Joint Contracture, Hypoaesthesia, Skin Induration, Gait Disturbance, Nephrogenic Systemic Fibrosis, Skin Disorder

An adverse event was reported by a consumer or non-health professional on Mar 15, 2012 by a male taking Magnevist (dosage: 20 Ml, Once) was diagnosed with and. Location: UNITED STATES , 79 years of age, patient began experiencing various side effects, including: Patient felt the following Magnevist side effects: muscular weakness, mobility decreased, depression, joint contracture, hypoaesthesia, skin induration, gait disturbance, nephrogenic systemic fibrosis, skin disorder. Additional medications/treatments:
Multiple prescriptions taken:
  • Warfarin Sodium (5 Mg, Qd)
  • Toprol-xl (2.5 Mg, Qd)
  • Simvastatin (20 Mg, Qd)
Anxiety, Skin Induration, Mobility Decreased, Pain, Skin Tightness, Fibrosis, Emotional Distress, Deformity, Coordination Abnormal

This Mobility Decreased problem was reported by a health professional from UNITED STATES. A female patient (weight: NA) was diagnosed with the following medical condition(s): imaging procedure.On May 17, 2004 a consumer started treatment with Magnevist (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Magnevist, the patient experienced the following unwanted symptoms /side effects:
  • Anxiety
  • Skin Induration
  • Mobility Decreased
  • Pain
  • Skin Tightness
  • Fibrosis
  • Emotional Distress
  • Deformity
  • Coordination Abnormal
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Mobility Decreased, may become evident only after a product is in use by the general population.
Anxiety, Joint Range Of Motion Decreased, Skin Fragility, Pain, Mobility Decreased, Nephrogenic Systemic Fibrosis, Spondyloarthropathy, Anhedonia, Renal Osteodystrophy

This is a Magnevist side effect report of a 63-year-old patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Magnevist (dosage: NA) starting Jul 17, 2006. Concurrently used drugs:
  • Norvasc (2.5 Mg, Bid)
  • Sensipar
  • Epogen (Unk)
  • Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl] (Unk)
  • Oxycodone Hcl (40 Mg, Tid)
  • Lebacarton (330 Mg, Tid)
  • Iron
Soon after that, the consumer experienced the following of symptoms:
  • Anxiety
  • Joint Range Of Motion Decreased
  • Skin Fragility
  • Pain
  • Mobility Decreased
  • Nephrogenic Systemic Fibrosis
  • Spondyloarthropathy
  • Anhedonia
  • Renal Osteodystrophy
This opens a possibility that Magnevist could cause Mobility Decreased and that some patients may be more susceptible.
Fibrosis, Skin Induration, Erythema, Skin Exfoliation, Oedema, Mobility Decreased, Pain, Cellulitis, Musculoskeletal Stiffness

This Mobility Decreased side effect was reported by a health professional from UNITED STATES on Feb 23, 2012. A female patient from UNITED STATES , weighting 171.0 lb, was diagnosed with and was treated with Magnevist. Patient felt the following Magnevist side effects: fibrosis, skin induration, erythema, skin exfoliation, oedema, mobility decreased, pain, cellulitis, musculoskeletal stiffness. Magnevist dosage: 20 Ml, Unk. These side effects may potentially be related to Magnevist.
1 of 18 

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Magnevist Mobility Decreased Causes and Reviews


We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.


Magnevist Mobility Decreased Reviews

No reviews submitted yet, check in later.

Common Drugs

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Top Magnevist Side Effects

Nephrogenic Systemic Fibrosis (920)
Urticaria (813)
Nausea (573)
Pruritus (551)
Dyspnoea (517)
Vomiting (511)
Erythema (507)
Anxiety (443)
Joint Range Of Motion Decreased (438)
Pain (425)
Oedema Peripheral (387)
Mobility Decreased (370)
Emotional Distress (361)
Fibrosis (341)
Arthralgia (330)
Deformity (265)
Joint Stiffness (253)
Injury (243)
Joint Contracture (240)
Gait Disturbance (232)
Sneezing (232)
Dry Skin (225)
Asthenia (223)
Anhedonia (222)
Pain In Extremity (207)
Burning Sensation (197)
Rash (192)
Musculoskeletal Stiffness (191)
Cough (187)
Hypoaesthesia (182)
Extremity Contracture (180)
Skin Induration (165)
Dizziness (162)
Muscular Weakness (160)
Skin Hypertrophy (156)
Throat Irritation (144)
Fatigue (144)
Skin Tightness (135)
Nephrogenic Fibrosing Dermopathy (131)
Chest Discomfort (131)
Feeling Hot (126)
Nasal Congestion (125)
Anaphylactic Reaction (114)
Throat Tightness (113)
Flushing (112)
Hyperhidrosis (102)
Convulsion (100)
Back Pain (99)
Chest Pain (98)
Skin Discolouration (98)

➢ More

Discuss Magnevist Side Effects